Assignee
MEDIMMUNE INC
US34 patents
Top patents by PatentIndex Score
US7083784B2Aug 1, 2006
Molecules with extended half-lives, compositions and uses thereof
MEDIMMUNE INC704 citations99
US7229619B1Jun 12, 2007
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC114 citations98
US6855493B2Feb 15, 2005
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC72 citations98
US6818216B2Nov 16, 2004
Anti-RSV antibodies
MEDIMMUNE INC165 citations98
US6656467B2Dec 2, 2003
Ultra high affinity neutralizing antibodies
MEDIMMUNE INC96 citations98
US7425618B2Sep 16, 2008
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
MEDIMMUNE INC55 citations97
US7122194B2Oct 17, 2006
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs
MEDIMMUNE INC83 citations97
US6689369B2Feb 10, 2004
Immunogenic pneumococcal protein and vaccine compositions thereof
MEDIMMUNE INC71 citations97
US6582706B1Jun 24, 2003
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
MEDIMMUNE INC106 citations97
US7323172B2Jan 29, 2008
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC48 citations96
US7179900B2Feb 20, 2007
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC45 citations96
US6565849B2May 20, 2003
Methods of enhancing activity of vaccines and vaccine compositions
MEDIMMUNE INC45 citations96
US5824307AOct 20, 1998
Human-murine chimeric antibodies against respiratory syncytial virus
MEDIMMUNE INC343 citations96
US7354584B2Apr 8, 2008
Recombinant IL-9 antibodies
MEDIMMUNE INC50 citations95
US7297337B2Nov 20, 2007
EphA2 T-cell epitopes and uses therefor
MEDIMMUNE INC26 citations95
US7294336B2Nov 13, 2007
Stabilized liquid anti-RSV antibody formulations
MEDIMMUNE INC37 citations95
US7132100B2Nov 7, 2006
Stabilized liquid anti-RSV antibody formulations
MEDIMMUNE INC49 citations95
US6416945B1Jul 9, 2002
Vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPS)
MEDIMMUNE INC57 citations94
US5583038ADec 10, 1996
Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
MEDIMMUNE INC98 citations94
US6503511B1Jan 7, 2003
Derivatives of choline binding proteins for vaccines
MEDIMMUNE INC27 citations92
US6261765B1Jul 17, 2001
In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)
MEDIMMUNE INC23 citations90
US7371383B2May 13, 2008
Recombinant anti-interleukin-9 antibodies
MEDIMMUNE INC21 citations89
US6908613B2Jun 21, 2005
Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
MEDIMMUNE INC21 citations89
US6833356B1Dec 21, 2004
Pneumococcal protein homologs and fragments for vaccines
MEDIMMUNE INC42 citations89
US7351533B2Apr 1, 2008
In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
MEDIMMUNE INC27 citations88
US6500434B1Dec 31, 2002
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
MEDIMMUNE INC27 citations88
US5736367AApr 7, 1998
Vectors and prokaryotes which autocatalytically delete antibiotic resistance
MEDIMMUNE INC27 citations86
US6737063B2May 18, 2004
FimH adhesin proteins and methods of use
MEDIMMUNE INC23 citations83
US6962701B2Nov 8, 2005
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
MEDIMMUNE INC8 citations74
US7435421B2Oct 14, 2008
Derivatives of choline binding proteins for vaccines
MEDIMMUNE INC6 citations73
US6887480B1May 3, 2005
Streptococcus pneumoniae proteins and vaccines
MEDIMMUNE INC10 citations73
US6863893B2Mar 8, 2005
Derivatives of choline binding proteins for vaccines
MEDIMMUNE INC10 citations73
US6962777B1Nov 8, 2005
In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
MEDIMMUNE INC10 citations69
US7309490B2Dec 18, 2007
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
MEDIMMUNE INC0 citations52